POU5F1 and osteosarcoma: Therefore, the treatment of osteosarcoma cells with this drug resulted in a reduced formation of self-renewing sarcospheres, a decreased expression of pluripotency markers (Nanog, OCT3/4) and the induction of cell death in CSC subpopulations [85,86].